Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Funny to see

<< Previous

Bullboard Posts

Next >>

Comment by Inthepezon Sep 30, 2021 10:02am

77 Views

Post# 33943003

RE:RE:Funny to see

That’s your job. To lie about the company and pretend you even own shares.

I challenge you to post your shares and
your average price lmao.

Rarbar99 wrote:

Inthepez wrote: Yukon “spam the board” Jizza is thinking about me at 3:30am lmao.

say what you want about Yukon, but at least he doesn't have to lie about his average price.

To be bullish on this company is one thing, but now miserable do you have to be to lie about how much money you've lost?